BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15348624)

  • 1. Polymorphism of 17-beta estradiol in a transdermal drug delivery system.
    Variankaval NE; Jacob KI; Dinh SM
    J Mater Sci Mater Med; 2002 Mar; 13(3):271-80. PubMed ID: 15348624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization of beta-estradiol in an acrylic transdermal drug delivery system.
    Variankaval NE; Jacob KI; Dinh SM
    J Biomed Mater Res; 1999 Mar; 44(4):397-406. PubMed ID: 10397943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adhesive layer thickness and drug loading on estradiol crystallization in a transdermal drug delivery system.
    Imani M; Lahooti-Fard F; Taghizadeh SM; Takrousta M
    AAPS PharmSciTech; 2010 Sep; 11(3):1268-75. PubMed ID: 20706877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems.
    Lipp R; Müller-Fahrnow A
    Eur J Pharm Biopharm; 1999 Mar; 47(2):133-8. PubMed ID: 10234537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.
    Latsch S; Selzer T; Fink L; Kreuter J
    Eur J Pharm Biopharm; 2003 Jul; 56(1):43-52. PubMed ID: 12837480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems.
    Latsch S; Selzer T; Fink L; Horstmann M; Kreuter J
    Eur J Pharm Biopharm; 2004 Mar; 57(2):397-410. PubMed ID: 15019001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
    Rohr UD; Nauert C; Ehrly AM
    Zentralbl Gynakol; 1995; 117(10):531-9. PubMed ID: 7491836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anhydrous β-guanine crystals in a marine dinoflagellate: Structure and suggested function.
    Jantschke A; Pinkas I; Hirsch A; Elad N; Schertel A; Addadi L; Weiner S
    J Struct Biol; 2019 Jul; 207(1):12-20. PubMed ID: 30991101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of CP/MAS solid-state NMR for the characterization of solvate molecules within estradiol crystal forms.
    Park JS; Kang HW; Park SJ; Kim CK
    Eur J Pharm Biopharm; 2005 Aug; 60(3):407-12. PubMed ID: 15996582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vibrational and thermal analyses of multicomponent crystal forms of the anti-HIV drugs lamivudine and zalcitabine.
    Martins FT; Guimarães FF; Honorato SB; Ayala AP; Ellena J
    J Pharm Biomed Anal; 2015 Jun; 110():76-82. PubMed ID: 25808817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acrylic resins as rate-controlling membranes in novel formulation of a nine-day 17beta-estradiol transdermal delivery system: in vitro and release modifier effect evaluation.
    Rafiee-Tehrani M; Safaii-Nikui N; Peteriet H; Beckert T
    Drug Dev Ind Pharm; 2001 May; 27(5):431-7. PubMed ID: 11448050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative absorption and variability in absorption of estradiol from a transdermal gel and a novel matrix-type transdermal patch.
    Järvinen A; Bäckström A; Elfström C; Viitanen A
    Maturitas; 2001 Apr; 38(2):189-96. PubMed ID: 11306208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Characterization, and Crystal Chemistry of Tasimelteon, a Melatonin Agonist, in Its Anhydrous and Hemihydrate Forms.
    Ventimiglia G; Bellomi S; Barreca G; Giovannelli L; Masciocchi N
    J Pharm Sci; 2018 Feb; 107(2):543-549. PubMed ID: 28947337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of casting solvent on crystallinity of ondansetron in transdermal films.
    Pattnaik S; Swain K; Mallick S; Lin Z
    Int J Pharm; 2011 Mar; 406(1-2):106-10. PubMed ID: 21237257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems.
    Attama AA; Schicke BC; Müller-Goymann CC
    Eur J Pharm Biopharm; 2006 Nov; 64(3):294-306. PubMed ID: 16949805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal, X-ray Structural, and Dissolution Characteristics of Solid Forms Derived from the Anticancer Agents 2-Methoxyestradiol and 2-Methoxyestradiol-3,17-O,O-Bis-Sulfamate.
    Caira MR; Bourne SA; Samsodien H
    J Pharm Sci; 2015 Oct; 104(10):3418-25. PubMed ID: 26073557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New trends in transdermal technologies: development of the skin patch, Menorest.
    Marty JP
    Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S17-20. PubMed ID: 8666122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic and Spectroscopic Imaging and Thermal Analysis of Acrylates, Silicones and Active Pharmaceutical Ingredients in Adhesive Transdermal Patches.
    Mikolaszek B; Jamrógiewicz M; Mojsiewicz-Pieńkowska K; Sznitowska M
    Polymers (Basel); 2022 Jul; 14(14):. PubMed ID: 35890664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between structural and thermal properties of anhydrous and solvated crystalline forms of brodimoprim.
    Caira MR; Bettinetti G; Sorrenti M; Catenacci L
    J Pharm Sci; 2007 May; 96(5):996-1007. PubMed ID: 17455357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.